Given the escalating high burdens of overeight and obesity, and related commobidies in Asia, Asian women with overweight/obesity is an important group for targeted intervention in promoting health and wellbeing. A study focused on Asian women at reproductive or early post-menopausal age can inform effective strategies for promoting healthy diet and lifetyle and for optimizing health not only among these women but also for their children and partners. The Mediterranean diet has beneficial effects on cardiometabolic and reproductive health. So far, evidence on the Mediterranean diet and its health benefits mostly come from Western populations. Studies evaluating health effects of Mediterranean diet in Asian population are scant. This study aims to investigate the beneficial effects of a healthy, Mediterranean-inspired localized diet (i.e., Asian-Mediterranean diet) on women's health, such as cardiometabolic health with potential mechanisms through modulating gut and brain health.
This study is a two-arm, single-centre, randomized controlled trial (RCT) involving up to 300 women of Chinese ethnicity in Singapore between 21-50 years old. Upon enrollment, participants will be randomized into one of two study arms (Intervention (up to 150 women), Control (up to 150 women)) in 1:1 ratio.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
300
For participants assigned to the intervention arm, the dietary intervention consists of: a) pre-cooked Asian-Mediterranean meals: participants will receive free meals, two meals a day, five days a week, and b) pre-packed nuts, 30g a day, five days a week, during the intervention period. Additionally, participants will receive a dietary consultation session at baseline and every four weeks.
For participants assigned to the control arm, they will receive a leaflet with dietary advice based on national guidelines at baseline.
Global Centre for Asian Women's Health
Singapore, Singapore, Singapore
RECRUITINGHigh-density lipoprotein cholesterol (HDL-C)
High-density lipoprotein cholesterol (HDL-C) in mg/dL (blood draw)
Time frame: week 0, week 12, and up to week 20
Low-density lipoprotein cholesterol (LDL-C)
Low-density lipoprotein cholesterol (LDL-C) in mg/dL (blood draw)
Time frame: week 0, week 12, and up to week 20
Low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol (HDL-C) ratio
Low-density lipoprotein cholesterol (LDL-C) in mg/dL and high-density lipoprotein cholesterol (HDL-C) in mg/dL (blood draw) to derive LDL-C to HDL-C ratio
Time frame: week 0, week 12, and up to week 20
Triglycerides
Triglycerides in mg/dL (blood draw)
Time frame: week 0, week 12, and up to week 20
Interleukin-6 (IL-6)
Interleukin-6 (IL-6) in pg/mL (blood draw)
Time frame: week 0, week 12, and up to week 20
C-reactive protein (CRP)
C-reactive protein (CRP) in mg/L (blood draw)
Time frame: week 0, week 12, and up to week 20
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.